These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33819206)

  • 21. Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.
    Jacobson DL; Patel K; Williams PL; Geffner ME; Siberry GK; DiMeglio LA; Crain MJ; Mirza A; Chen JS; McFarland E; Kacanek D; Silio M; Rich K; Borkowsky W; Van Dyke RB; Miller TL;
    Pediatr Infect Dis J; 2017 Feb; 36(2):189-197. PubMed ID: 27798548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe.
    Ntozini R; Chandna J; Evans C; Chasekwa B; Majo FD; Kandawasvika G; Tavengwa NV; Mutasa B; Mutasa K; Moulton LH; Humphrey JH; Gladstone MJ; Prendergast AJ;
    J Int AIDS Soc; 2020 May; 23(5):e25456. PubMed ID: 32386127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.
    Kakuru A; Natureeba P; Muhindo MK; Clark TD; Havlir DV; Cohan D; Dorsey G; Kamya MR; Ruel T
    Malar J; 2016 Oct; 15(1):500. PubMed ID: 27756308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Undernutrition of HEU infants in their first 1000 days of life: A case in the urban-low resource setting of Mukuru Slum, Nairobi, Kenya.
    Wambura JN; Marnane B
    Heliyon; 2019 Jul; 5(7):e02073. PubMed ID: 31372539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A description of early neurodevelopment in a cohort of HIV-exposed uninfected children.
    Strehlau R; van Aswegen T; Burke M; Kuhn L; Potterton J
    AIDS Care; 2020 Nov; 32(11):1421-1428. PubMed ID: 32122174
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.
    Rosala-Hallas A; Bartlett JW; Filteau S
    BMC Pediatr; 2017 Mar; 17(1):80. PubMed ID: 28302082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.
    Miller TL; Easley KA; Zhang W; Orav EJ; Bier DM; Luder E; Ting A; Shearer WT; Vargas JH; Lipshultz SE; ;
    Pediatrics; 2001 Dec; 108(6):1287-96. PubMed ID: 11731650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.
    Siberry GK; Williams PL; Mendez H; Seage GR; Jacobson DL; Hazra R; Rich KC; Griner R; Tassiopoulos K; Kacanek D; Mofenson LM; Miller T; DiMeglio LA; Watts DH;
    AIDS; 2012 Jun; 26(9):1151-9. PubMed ID: 22382151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana.
    Powis K; Lockman S; Smeaton L; Hughes MD; Fawzi W; Ogwu A; Moyo S; van Widenfelt E; von Oettingen J; Makhema J; Essex M; Shapiro RL
    Pediatr Infect Dis J; 2014 Nov; 33(11):1141-7. PubMed ID: 25037041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda.
    Aizire J; Sikorskii A; Ogwang LW; Kawalazira R; Mutebe A; Familiar-Lopez I; Mallewa M; Taha T; Boivin MJ; Fowler MG;
    AIDS; 2020 Feb; 34(2):215-225. PubMed ID: 31634154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of growth in HIV-exposed and HIV-uninfected infants in the Kabeho Study.
    Lane CE; Bobrow EA; Ndatimana D; Ndayisaba GF; Adair LS
    Matern Child Nutr; 2019 Jul; 15(3):e12776. PubMed ID: 30609287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth and Neurodevelopment Outcomes in HIV-, Tenofovir-, and Efavirenz-Exposed Breastfed Infants in the PMTCT Option B+ Program in Malawi.
    Kapito-Tembo AP; Bauleni A; Wesevich A; Ongubo D; Hosseinipour MC; Dube Q; Mwale P; Corbett A; Mwapasa V; Phiri S
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):81-90. PubMed ID: 33027153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.
    Cherkos AS; LaCourse SM; Enquobahrie DA; Richardson BA; Bradford S; Montepiedra G; Mmbaga BT; Mbengeranwa T; Masheto G; Jean-Phillippe P; Chakhtoura N; Theron G; Weinberg A; Cassim H; Raesi MS; Jean E; Wabwire D; Nematadzira T; Stranix-Chibanda L; Hesseling AC; Aurpibul L; Gupta A; John-Stewart G;
    EClinicalMedicine; 2023 Apr; 58():101912. PubMed ID: 36969345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
    Morden E; Technau KG; Giddy J; Maxwell N; Keiser O; Davies MA
    PLoS One; 2016; 11(4):e0151762. PubMed ID: 27049853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between gestational anthropometry, maternal HIV, and fetal and early infancy growth in a prospective rural/semi-rural Tanzanian cohort, 2012-13.
    Wilkinson AL; Pedersen SH; Urassa M; Michael D; Todd J; Kinung'hi S; Changalucha J; McDermid JM
    BMC Pregnancy Childbirth; 2015 Oct; 15():277. PubMed ID: 26515916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort.
    Moseholm E; Helleberg M; Sandholdt H; Katzenstein TL; Storgaard M; Pedersen G; Johansen IS; Weis N
    Clin Infect Dis; 2020 May; 70(10):2168-2177. PubMed ID: 31271208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.
    Onyango-Makumbi C; Owora AH; Mwiru RS; Mwatha A; Young AM; Moodley D; Coovadia HM; Stranix-Chibanda L; Manji K; Maldonado Y; Richardson P; Andrew P; George K; Fawzi W; Fowler MG
    J Acquir Immune Defic Syndr; 2019 Dec; 82(4):377-385. PubMed ID: 31567725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.